187 related articles for article (PubMed ID: 35503407)
1. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
Chen Z; Tang W; Ye W; Song L; Chen Z
Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A; Jin C; Li H; Qin Q; Li L
Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
[TBL] [Abstract][Full Text] [Related]
3. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
5. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
Shi YF; Lu H; Wang HB
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
[TBL] [Abstract][Full Text] [Related]
6. A review on the role of ADAMTS9-AS2 in different disorders.
Ghafouri-Fard S; Askari A; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
Pathol Res Pract; 2023 Mar; 243():154346. PubMed ID: 36746036
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS9-AS2 Promotes Angiogenesis of Brain Microvascular Endothelial Cells Through Regulating miR-185-5p/IGFBP-2 Axis in Ischemic Stroke.
Feng N; Wang Z; Wu Y; Zheng H; Jiang X; Wang Z; Qu F; Zhang Z
Mol Neurobiol; 2022 Apr; 59(4):2593-2604. PubMed ID: 35098480
[TBL] [Abstract][Full Text] [Related]
8. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
Guo Q; Ni P; Dai Y; Hu J; Yao Y
J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133
[TBL] [Abstract][Full Text] [Related]
9. Lnc RNA ZFAS1 regulates the proliferation, apoptosis, inflammatory response and autophagy of fibroblast-like synoviocytes via miR-2682-5p/ADAMTS9 axis in rheumatoid arthritis.
Yang S; Yin W; Ding Y; Liu F
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744323
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC00629 restrains the progression of gastric cancer by upregulating AQP4 through competitively binding to miR-196b-5p.
Li J; Wang L; He F; Li B; Han R
J Cell Physiol; 2020 Mar; 235(3):2973-2985. PubMed ID: 31674022
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
[TBL] [Abstract][Full Text] [Related]
12. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA ADAMTS9-AS1/miR-185-5p/KAT7 ceRNA network inhibits cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy.
Song B; Li W; Xu X; Dang H; Dong R
Biomed Res; 2023; 44(3):105-115. PubMed ID: 37258203
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
[TBL] [Abstract][Full Text] [Related]
15. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
[TBL] [Abstract][Full Text] [Related]
16.
Shen FF; Zhang F; Yang HJ; Li JK; Su JF; Yu PT; Zhou FY; Che GW
Biomark Med; 2020 Oct; 14(15):1415-1426. PubMed ID: 32892630
[No Abstract] [Full Text] [Related]
17. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
Lu T; Wang R; Cai H; Cui Y
Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
[TBL] [Abstract][Full Text] [Related]
19. miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer.
Zhang L; Wang X; Liu X; Lv M; Shen E; Zhu G; Sun Z
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):842-852. PubMed ID: 32645138
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]